|
Market Closed -
Sao Paulo
09:02:10 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 143.40 BRL | +3.91% |
|
0.00% | +19.38% |
| 10-09 | Exelixis' Zanzalintinib Clinical Trials for Cancer Highly Likely to Succeed, RBC Says | MT |
| 10-09 | RBC Raises Price Target on Exelixis to $51 From $45, Keeps Sector Perform Rating | MT |
Stock exchange
Sao Paulo
E2XE34 143.40 R$
+3.91%
143.4
R$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| EXEL | 64.53USD | -1.19% | 133M $ | ||
CBOE
| EXEL | 64.56USD | -1.12% | 6.21M $ | |
|
Börse Stuttgart
| EX9 | 57.66EUR | -0.64% | 37.65K € | |
|
Borsa Italiana
| 1EXEL | 51.99EUR | -0.33% | 15.44K € | |
|
Berne S.E.
| EX9 | 53.21CHF | +1.14% | 10.64K CHF | |
|
Tradegate
| EX9 | 57.66EUR | -0.98% | 6.75K € | |
|
Boerse Muenchen
| EX9 | 57.88EUR | -0.21% | 1.91K € | |
|
Deutsche Boerse AG
| EX9 | 57.61EUR | -1.00% | 0 € | |
| E2XE34 | 143.40BRL | +3.91% | 143.4 R$ |
Performance
| 1 day | +3.91% | ||
| Current month | +4.37% | ||
| 1 month | +4.37% | ||
| 3 months | +6.68% | ||
| 6 months | +29.33% | ||
| Current year | +19.38% | ||
| 1 year | +34.12% | ||
| 3 years | +221.31% |
Volumes
marketsDaily volume
1
Estimated daily volume
1
Avg. Volume 20 sessions
1
Daily volume ratio
1
Avg. Volume 20 sessions BRL
143.4
Avg. Volume 20 sessions USD
28.7
Record volume 1
2,788
Record volume 2
2,561
Record volume 3
1,441
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (BRL)
15,989,352,584
Market Cap (USD)
15,989,352,584
Net sales (USD)
2,320,126,000
Number of employees
1,077
Sales / Employee (USD)
2,154,249
Free-Float
98.15%
Free-Float capitalization (BRL)
3,115,492,938
Free-Float capitalization (USD)
15,694,295,677
Average Daily Capital Traded
-.--%
Indicators
Moving average 20 days
124.15
Moving average 50 days
88.12
Moving average 100 days
133.99
Price spread / (MMA20)
-13.42%
Price spread / (MMA50)
-38.55%
Price spread / (MMA100)
-6.56%
RSI 9 days
70.81
RSI 14 days
71.28
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.91% | 0.00% | +34.12% | +221.31% | 15.99B | |
| +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | |
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | |
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | |
| Average | +0.64% | +2.41% | +47.97% | +163.93% | 39.91B | |
| Weighted average by Cap. | +0.53% | +2.73% | +47.03% | +161.09% |
Historical Quotes: Exelixis, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 month | 143.4 |  | 143.4 |
| Current year | 104.72 | | 143.4 |
| 1 year | 98.24 | | 143.4 |
| 3 years | 50.71 | | 143.4 |
| 5 years | 40 | | 143.4 |
| 10 years | 40 | | 143.4 |
Monthly variations
Annual variations
| 2026 | +19.38% | ||
| 2025 | +13.53% | ||
| 2024 | +106.84% | ||
| 2023 | +14.61% | ||
| 2022 | -7.84% |
- Stock Market
- Stocks
- EXEL Stock
- E2XE34 Stock
- Quotes Exelixis, Inc.
Select your edition
All financial news and data tailored to specific country editions
